There have been 50 recent insider transactions recorded for Q32 Bio Inc. (QTTB), including 24 buys and 25 sells. Total insider buying was valued at $2.66M and total insider selling at $4.64M.
Notable insiders with recent activity include Morrison Jodie Pope, Kalowski Lee, Violette Shelia M.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — QTTB
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-25 |
Morrison Jodie Pope |
CEO |
Informative Sell |
9,896 |
$4.51 |
$44.67K |
89,104 |
| 2026-02-25 |
Kalowski Lee |
CFO and President |
Informative Sell |
3,995 |
$4.51 |
$18.04K |
35,943 |
| 2026-02-25 |
Violette Shelia M. |
Chief Scientific Officer |
Informative Sell |
2,815 |
$4.51 |
$12.71K |
55,569 |
| 2026-02-24 |
Morrison Jodie Pope |
CEO |
RSU Award |
132,000 |
- |
- |
221,104 |
| 2026-02-24 |
Kalowski Lee |
CFO and President |
RSU Award |
53,250 |
- |
- |
89,193 |
| 2026-02-24 |
Violette Shelia M. |
Chief Scientific Officer |
RSU Award |
37,500 |
- |
- |
93,069 |
| 2026-01-15 |
Laporte Kathleen |
Director |
RSU Award |
23,272 |
$3.60 |
$83.78K |
23,272 |
| 2026-01-15 |
Lundberg Sven Ante |
Director |
RSU Award |
20,363 |
$3.60 |
$73.31K |
20,363 |
| 2026-01-15 |
Grayzel David S. |
Director |
RSU Award |
16,363 |
$3.60 |
$58.91K |
16,363 |
| 2025-12-02 |
Morrison Jodie Pope |
CEO |
Informative Sell |
22,506 |
$3.46 |
$77.87K |
99,000 |
| 2025-12-02 |
Kalowski Lee |
CFO and President |
Informative Sell |
9,072 |
$3.46 |
$31.4K |
39,938 |
| 2025-10-23 |
Laporte Kathleen |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Thistle Mary |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Iwicki Mark T |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Tzianabos Arthur |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Manke Isaac |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Lundberg Sven Ante |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Grayzel David S. |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-10-23 |
Xu Diyong |
Director |
RSU Award |
53,521 |
$2.80 |
$149.86K |
53,521 |
| 2025-08-26 |
Morrison Jodie Pope |
CEO |
Informative Sell |
10,494 |
$1.80 |
$18.9K |
121,506 |
| 2025-08-26 |
Kalowski Lee |
CFO and President |
Informative Sell |
4,240 |
$1.80 |
$7.64K |
49,010 |
| 2025-08-26 |
Violette Shelia M. |
Chief Scientific Officer |
Informative Sell |
2,990 |
$1.80 |
$5.38K |
58,384 |
| 2025-02-24 |
Thistle Mary |
Director |
Return of Shares |
12,767 |
$16.82 |
$214.74K |
- |
| 2025-02-24 |
Iwicki Mark T |
Director |
Return of Shares |
25,534 |
$16.82 |
$429.48K |
- |
| 2025-02-24 |
Morrison Jodie Pope |
CEO |
Return of Shares |
152,700 |
$7.50 |
$1.15M |
- |
| 2025-02-24 |
Lundberg Sven Ante |
Director |
Return of Shares |
12,767 |
$16.82 |
$214.74K |
- |
| 2025-02-24 |
Grayzel David S. |
Director |
Return of Shares |
18,595 |
$3.20 |
$59.5K |
- |
| 2025-02-24 |
Campagna Jason |
Chief Medical Officer |
Return of Shares |
70,687 |
$16.82 |
$1.19M |
- |
| 2025-02-24 |
Xu Diyong |
Director |
Return of Shares |
12,767 |
$16.82 |
$214.74K |
- |
| 2025-02-24 |
Violette Shelia M. |
Chief Scientific Officer |
Return of Shares |
13,305 |
$7.29 |
$96.99K |
- |
| 2025-02-24 |
Laporte Kathleen |
Director |
Return of Shares |
1,947 |
$7.29 |
$14.19K |
- |
| 2025-02-24 |
Tzianabos Arthur |
Director |
Return of Shares |
12,767 |
$16.82 |
$214.74K |
- |
| 2025-02-24 |
Kalowski Lee |
CFO and President |
Return of Shares |
16,901 |
$17.08 |
$288.67K |
- |
| 2025-02-24 |
Manke Isaac |
Director |
Return of Shares |
12,767 |
$16.82 |
$214.74K |
- |
| 2025-01-15 |
Lundberg Sven Ante |
Director |
RSU Award |
23,140 |
$3.20 |
$74.05K |
23,140 |
| 2025-01-15 |
Grayzel David S. |
Director |
RSU Award |
18,595 |
$3.20 |
$59.5K |
18,595 |
| 2025-01-15 |
Manke Isaac |
Director |
RSU Award |
19,008 |
$3.20 |
$60.83K |
19,008 |
| 2024-10-15 |
Violette Shelia M. |
Chief Scientific Officer |
Option Exercise |
6,000 |
$7.29 |
$43.74K |
23,874 |
| 2024-10-11 |
Violette Shelia M. |
Chief Scientific Officer |
Option Exercise (Sell) |
4,361 |
$3.12 |
$13.61K |
- |
| 2024-10-08 |
Violette Shelia M. |
Chief Scientific Officer |
Option Exercise (Sell) |
13,300 |
$3.12 |
$41.5K |
213 |
| 2024-09-25 |
Lundberg Sven Ante |
Director |
RSU Award |
1,316 |
$44.40 |
$58.43K |
1,316 |
| 2024-04-01 |
Grayzel David S. |
Director |
RSU Award |
2,569 |
$18.00 |
$46.24K |
2,569 |
| 2024-04-01 |
Manke Isaac |
Director |
RSU Award |
2,627 |
$18.00 |
$47.29K |
2,627 |
| 2024-03-25 |
Tzianabos Arthur |
Director |
Option Exercise (Sell) |
1,095 |
- |
- |
- |
| 2024-03-25 |
Orbimed Advisors Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
2,252,987 |
| 2024-03-25 |
Laporte Kathleen |
Director |
Disposition |
1,947 |
$7.29 |
$14.19K |
- |
| 2024-03-25 |
Laporte Kathleen |
Director |
RSU Award |
12,767 |
$16.82 |
$214.74K |
12,767 |
| 2024-03-25 |
Thistle Mary |
Director |
RSU Award |
12,767 |
$16.82 |
$214.74K |
12,767 |
| 2024-03-25 |
Iwicki Mark T |
Director |
Disposition |
7,615 |
$7.29 |
$55.51K |
- |
| 2024-03-25 |
Iwicki Mark T |
Director |
RSU Award |
25,534 |
$16.82 |
$429.48K |
25,534 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
